Laurie Huston
Family · Beulah, NDNPI 1215901228
Payments from drug & device makers
Across 27 payments — averaging $23.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acadia Pharmaceuticals Inc$212
- Lexicon Pharmaceuticals, Inc.$77
- Astellas Pharma US Inc$73
- Relievant Medsystems, Inc.$65
- Johnson & Johnson$56
- Lundbeck LLC$37
- plus $109 from 5 others
What the payments were for
- Food & beverage$629100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acadia Pharmaceuticals Inc | 6 | $212 |
| Lexicon Pharmaceuticals, Inc. | 4 | $77 |
| Astellas Pharma US Inc | 5 | $73 |
| Relievant Medsystems, Inc. | 2 | $65 |
| Johnson & Johnson | 3 | $56 |
| Lundbeck LLC | 2 | $37 |
| AbbVie | 1 | $33 |
| Organogenesis Inc. | 1 | $23 |
| Boehringer Ingelheim | 1 | $18 |
| Radius Health, Inc. | 1 | $17 |
| Neurocrine Biosciences, Inc. | 1 | $17 |
How this compares
$629 in reported general payments places this provider in the 75th percentile of 496 family providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 338 | $98,880 |
| JanuviaSitagliptin Phosphate | 120 | $31,115 |
| MyrbetriqMirabegron | 102 | $23,682 |
| JardianceEmpagliflozin | 73 | $22,008 |
| XareltoRivaroxaban | 74 | $20,894 |
| TrulicityDulaglutide | 19 | $19,745 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 49 | $14,739 |
| MovantikNaloxegol Oxalate | 67 | $12,391 |
| RestasisCyclosporine | 32 | $11,074 |
| LinzessLinaclotide | 17 | $9,778 |
| Spiriva RespimatTiotropium Bromide | 16 | $8,979 |
| EntrestoSacubitril/Valsartan | 25 | $8,385 |
| Potassium Chloride | 220 | $6,548 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $5,556 |
| OxycontinOxycodone Hcl | 18 | $5,231 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Spiriva Respimat | $18 | $30,98789 claims |
| Astellas Pharma US IncMyrbetriq | $73 | $23,682102 claims |
| Johnson & JohnsonXarelto | $56 | $20,89474 claims |
| AbbVieRestasis, Linzess | $33 | $20,85149 claims |
| Lexicon Pharmaceuticals, Inc.Inpefa | $77 | $4,38615 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 496 family providers in North Dakota.
Other family in Beulah
- Christina DahlJamestown$26K
- Coralyn Jensen KurtzGrand Forks$12K
- Paula RickeGrand Forks$9K
- Courtney WoodburyBismarck$8K
- Monica GoetzBismarck$8K
- Danielle EidenschinkFargo$6K
- Chantel HillestadMinot$6K
- Elizabeth ScheurerBismarck$6K
- Kayla HolzerBismarck$5K
- Amanda AllmarasBismarck$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.